Skip to content

World of DTC Marketing.com

Healthcare is changing by necessity
Main navigation
  • Home
  • Stats & Facts
  • Health Facts & Stats
  • About Me

Novo

Novo’s obesity drug has serious warnings and barriers to overcome

W W Read More

SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?

Continue reading →
Posted on June 6, 2021June 6, 2021 Focus on patientsin the newsProduct Launches
© 2023 World of DTC Marketing.com. Made with love by Pixelgrade
  • Home
  • About Me
  • Health Facts & Stats
  • Stats & Facts
Secondary navigation
  • Search

Begin typing your search above and press return to search. Press Esc to cancel.